source
- Sandoz to Pay $478.5 Million to Settle Generic Drug Price-Fixing ClaimsSandoz has agreed to pay $478.5 million to resolve allegations that it participated in a widespread conspiracy to inflate and manipulate the prices of generic medicines. Dozens of U.S. states and i…
- Eli Lilly’s one-patient early access to retatrutide leaves doctors seeking answersEli Lilly granted a single 79-year-old patient special access to retatrutide, an experimental obesity drug that has shown weight‑loss results comparable to bariatric surgery. Since that decision,…